Testing for NTRK Gene Fusions in the Community Setting
Alexander Drilon, MD, discusses what community oncologists should know about testing for NTRK gene fusions in patients with solid tumors.
Differentiating TRK Proteins in Adults and Adolescents With Solid Tumors
Alexander Drilon, MD, discusses the differences in how TRK fusions manifest in older patients vs younger patients.
Next Steps for LOXO-292 in RET-Mutant Medullary Thyroid Cancer
Alexander E. Drilon, MD, discusses the next steps for LOXO-292 in 2 subsets of patients: those with RET fusion-positive cancers and <em>RET</em>-mutant medullary thyroid cancers.
Prevalence of RET Mutations in Lung and Thyroid Cancers
Alexander E. Drilon, MD, discusses the prevalence of <em>RET</em> fusions and mutations in patients with cancer, including lung and thyroid cancers.
